Ascorbic Acid-Eluting Implantable Medical Devices, Systems, and Related Methods
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 2, 2015
app pub date -
Jul 23, 2013
filing date -
Aug 6, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Implantable medical devices may elute drugs that promote the growth of endothelial cells while inhibiting the growth of smooth muscle cells. In some instances, implantable medical devices may elute L-ascorbic acid, or vitamin C. In some instances, an implantable medical device configured to elute L-ascorbic acid may be a stent, although a variety of other implantable medical devices are contemplated.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully